134 related articles for article (PubMed ID: 35202850)
1. Combinatorial assembly, traceless generation and in situ evaluation of inhibitors for therapeutically relevant serine proteases.
Vu LP; Zyulina M; Hingst A; Schnakenburg G; Gütschow M
Bioorg Chem; 2022 Apr; 121():105676. PubMed ID: 35202850
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of the active site caging of serine proteases: thrombin and factor Xa.
Thuring JW; Li H; Porter NA
Biochemistry; 2002 Feb; 41(6):2002-13. PubMed ID: 11827547
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in serine protease inhibitors as anticoagulant agents.
Prezelj A; Anderluh PS; Peternel L; Urleb U
Curr Pharm Des; 2007; 13(3):287-312. PubMed ID: 17313362
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of serine proteinases from blood coagulation cascade - view on current developments.
Danalev D
Mini Rev Med Chem; 2012 Jul; 12(8):721-30. PubMed ID: 22512557
[TBL] [Abstract][Full Text] [Related]
5. Structure-Based Design of High-Affinity and Selective Peptidomimetic Hepsin Inhibitors.
Knaff PM; Müller P; Kersten C; Wettstein L; Münch J; Landfester K; Mailänder V
Biomacromolecules; 2022 Jun; 23(6):2236-2242. PubMed ID: 35593713
[TBL] [Abstract][Full Text] [Related]
6. Similarity study of serine proteases inhibitors.
Perekhodtsev GD
Mol Divers; 2006 Feb; 10(1):81-3. PubMed ID: 16404529
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a novel, potent, and specific family of factor Xa inhibitors via combinatorial chemistry.
Ostrem JA; al-Obeidi F; Safar P; Safarova A; Stringer SK; Patek M; Cross MT; Spoonamore J; LoCascio JC; Kasireddy P; Thorpe DS; Sepetov N; Lebl M; Wildgoose P; Strop P
Biochemistry; 1998 Jan; 37(4):1053-9. PubMed ID: 9454596
[TBL] [Abstract][Full Text] [Related]
8. Development of Trypsin-Like Serine Protease Inhibitors as Therapeutic Agents: Opportunities, Challenges, and their Unique Structure-Based Rationales.
Liang G; Bowen JP
Curr Top Med Chem; 2016; 16(13):1506-29. PubMed ID: 26369819
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of bisbenzamidines as inhibitors for matriptase-2.
Beckmann AM; Gilberg E; Gattner S; Huang TL; Vanden Eynde JJ; Mayence A; Bajorath J; Stirnberg M; Gütschow M
Bioorg Med Chem Lett; 2016 Aug; 26(15):3741-5. PubMed ID: 27287367
[TBL] [Abstract][Full Text] [Related]
10. Effector cell protease receptor-1 is a vascular receptor for coagulation factor Xa.
Nicholson AC; Nachman RL; Altieri DC; Summers BD; Ruf W; Edgington TS; Hajjar DP
J Biol Chem; 1996 Nov; 271(45):28407-13. PubMed ID: 8910465
[TBL] [Abstract][Full Text] [Related]
11. Dual inhibitors of the blood coagulation enzymes.
Kranjc A; Kikelj D
Curr Med Chem; 2004 Oct; 11(19):2535-47. PubMed ID: 15544461
[TBL] [Abstract][Full Text] [Related]
12. Incorporation of neutral C-terminal residues in 3-amidinophenylalanine-derived matriptase inhibitors.
Schweinitz A; Dönnecke D; Ludwig A; Steinmetzer P; Schulze A; Kotthaus J; Wein S; Clement B; Steinmetzer T
Bioorg Med Chem Lett; 2009 Apr; 19(7):1960-5. PubMed ID: 19250826
[TBL] [Abstract][Full Text] [Related]
13. Improving the selectivity of 3-amidinophenylalanine-derived matriptase inhibitors.
Pilgram O; Keils A; Benary GE; Müller J; Merkl S; Ngaha S; Huber S; Chevillard F; Harbig A; Magdolen V; Heine A; Böttcher-Friebertshäuser E; Steinmetzer T
Eur J Med Chem; 2022 Aug; 238():114437. PubMed ID: 35635944
[TBL] [Abstract][Full Text] [Related]
14. Discovery and characterization of a potent and selective non-amidine inhibitor of human factor Xa.
Liang AM; Light DR; Kochanny M; Rumennik G; Trinh L; Lentz D; Post J; Morser J; Snider M
Biochem Pharmacol; 2003 May; 65(9):1407-18. PubMed ID: 12732352
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of factor Xa by a peptidyl-alpha-ketothiazole involves two steps. Evidence for a stabilizing conformational change.
Betz A; Wong PW; Sinha U
Biochemistry; 1999 Nov; 38(44):14582-91. PubMed ID: 10545181
[TBL] [Abstract][Full Text] [Related]
16. Crystal structures of human factor Xa complexed with potent inhibitors.
Maignan S; Guilloteau JP; Pouzieux S; Choi-Sledeski YM; Becker MR; Klein SI; Ewing WR; Pauls HW; Spada AP; Mikol V
J Med Chem; 2000 Aug; 43(17):3226-32. PubMed ID: 10966741
[TBL] [Abstract][Full Text] [Related]
17. Optimization of a coagulation factor VIIa inhibitor found in factor Xa inhibitor library.
Sagi K; Fujita K; Sugiki M; Takahashi M; Takehana S; Tashiro K; Kayahara T; Yamanashi M; Fukuda Y; Oono S; Okajima A; Iwata S; Shoji M; Sakurai K
Bioorg Med Chem; 2005 Mar; 13(5):1487-96. PubMed ID: 15698764
[TBL] [Abstract][Full Text] [Related]
18. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
[TBL] [Abstract][Full Text] [Related]
19. Coumarin and isocoumarin as serine protease inhibitors.
Pochet L; Frédérick R; Masereel B
Curr Pharm Des; 2004; 10(30):3781-96. PubMed ID: 15579071
[TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization, and the crystal structure of the inhibitor ZK-807834 (CI-1031) complexed with factor Xa.
Adler M; Davey DD; Phillips GB; Kim SH; Jancarik J; Rumennik G; Light DR; Whitlow M
Biochemistry; 2000 Oct; 39(41):12534-42. PubMed ID: 11027132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
